|
| CASE REPORT |
 |
|
|
| Year : 2021 |
Volume
: 32 | Issue : 6 | Page
: 1800-1803 |
|
Anti-phospholipase A2 Receptor Antibody-Positive Membranous Glomerulopathy due to Anti-Koch’s Therapy in a Tuberculosis Patient
Manish R. Balwani1, Amit S. Pasari1, Amol Bhawane2, Priyanka Tolani3
1 Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha; Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India
2 Department of Nephrology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India
3 Department of Medicine, Jawaharlal Nehru Medical College, Sawangi, Wardha; Department of Medicine, Saraswati Kidney Care Center, Nagpur, Maharashtra, India
Correspondence Address:
Manish R. Balwani
Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India.
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-2442.352444
|
|
|
Tuberculosis (TB)-associated glomerulonephritis is difficult to diagnose that usually presents with hematuria, proteinuria, edema, hypertension, or renal insufficiency, which is similar to symptoms of primary glomerulonephritis. Membranous nephropathy (MN) is uncommonly seen in TB patients. We report a case of a 30-year-old female with Koch’s chest who developed anti-phospholipase A2 receptor antibody-positive MN after initiation of anti-Koch’s therapy and resolved after completion of anti-Koch’s therapy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
|
|
